What's new! CIDG publications March 2022

During March 2022, the CIDG published two new reviews in Issue 3, 2022 of the Cochrane Database of Systematic Reviews, and published an updated Cochrane Special Collection on diagnosing tuberculosis. In addition, the CIDG review on hydroxychloroquine for COVID-19 was the joint winner of the inaugural Harding Prize for Useful and Trustworthy Communication!  


New Reviews

van't Hoog A, Viney K, Biermann O, Yang B, Leeflang MMG, Langendam MW. Symptom‐ and chest‐radiography screening for active pulmonary tuberculosis in HIV‐negative adults and adults with unknown HIV status. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD010890. DOI: 10.1002/14651858.CD010890

Ochodo EA, Olwanda EElizabeth, Deeks JJ, Mallett S. Point‐of‐care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD013208. DOI: 10.1002/14651858.CD013208.pub2

 Cochrane Special Collection 

An updated Cochrane Special Collection on diagnosing tuberculosis was published for World TB Day (24th March 2022). The Special Collection was curated by Mikashmi Kohli, Adrienne Shapiro, and Karen Steingart (Cochrane Infectious Diseases) and Nazir Ismail, Alexei Korobitsyn, and Cecily Miller (WHO Global Tuberculosis Programme). We thank CIDG Editor Karen Steingart for co-ordinating this collection over the years. 

Read more here:


World TB Day 2022 | LSTM (lstmed.ac.uk)


Harding Prize

The Cochrane Infectious Diseases Group Review of Hydroxychloroquine for COVID-1has been recognised with the inaugural Harding Prize for Useful and Trustworthy Communication. This prize celebrates individuals or teams who have communicated information in a trustworthy and useful way - that genuinely helped people decide what to do, or help them judge a decision made by others. Read more here. 

Throughout 2022, we will continue to add publications to our CIDG and READ-It websites regularly. Do continue to check our websites for updates and follow us on Twitter.

The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.